000 | 01552 a2200469 4500 | ||
---|---|---|---|
005 | 20250516033555.0 | ||
264 | 0 | _c20110726 | |
008 | 201107s 0 0 eng d | ||
022 | _a1791-7530 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkui, Tatsuo | |
245 | 0 | 0 |
_aAntitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma. _h[electronic resource] |
260 |
_bAnticancer research _cApr 2011 |
||
300 |
_a1197-204 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aIsoxazoles _xtherapeutic use |
650 | 0 | 4 |
_aMandibular Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aMouth Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
650 | 0 | 4 |
_aResorcinols _xtherapeutic use |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aShimo, Tsuyoshi | |
700 | 1 | _aHassan, Nur Mohammad Monsur | |
700 | 1 | _aFukazawa, Takuya | |
700 | 1 | _aKurio, Naito | |
700 | 1 | _aTakaoka, Munenori | |
700 | 1 | _aNaomoto, Yoshio | |
700 | 1 | _aSasaki, Akira | |
773 | 0 |
_tAnticancer research _gvol. 31 _gno. 4 _gp. 1197-204 |
|
999 |
_c20773842 _d20773842 |